In Brief This Week: Ventana; Paradigm; Thermo Fisher; Transgenomic; Atossa Genetics; SQI; 908 Devices | GenomeWeb

NEW YORK (GenomeWeb) – Roche's Ventana Medical Systems said that its Ventana System for Primary Diagnosis has received CE marking in the European Union for routine pathology, including primary diagnosis with human tissue specimens. The system comprises the Ventana Virtuoso software combined with either the Ventana iScan Coreo or the Ventana iScan HT slide scanner for the automated creation of digital slides, as well as automated case management and computer viewing of human tissue specimens. The iScan Coreo slide scanner is a brightfield 160-slide capacity scanner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.